1. Phase I trial of the mTOR inhibitor everolimus in combination with multi‐agent chemotherapy in relapsed childhood acute lymphoblastic leukemia. Issue 7 (30th March 2018) Authors: Place, Andrew E.; Pikman, Yana; Stevenson, Kristen E.; Harris, Marian H.; Pauly, Melinda; Sulis, Maria‐Luisa; Hijiya, Nobuko; Gore, Lia; Cooper, Todd M.; Loh, Mignon L.; Roti, Giovanni; Neuberg, Donna S.; Hunt, Sarah K.; Orloff‐Parry, Sarah; Stegmaier, Kimberly; Sallan, Stephen E.; Silverman, Lew... Journal: Pediatric blood & cancer Issue: Volume 65:Issue 7(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗